Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
There have been no new NHS prescriptions for full-extract cannabis oil since the medicinal use of the drug was legalised more than 18 months ago, the Guardian has established.
Wealthier families and those who can successfully raise funds pay about £2,000 a month to access full-leaf cannabis medicines via private prescription for children with rare forms of treatment-resistant epilepsy, while poorer parents are unable to afford the prescriptions.
Experts say that, despite the drug’s legality, rigid prescribing guidelines for doctors set by the British Paediatric Neurological Association – which cite a lack of clinical research and reference disputed theories about the mental health effects of cannabis – make getting hold of the medicine on the NHS difficult in practice.
A freedom of information (FoI) request to the NHS business services authority confirmed there were no new prescriptions for the oil in England between its legalisation and the end of February. There is understood to have been no change since.
Wealthier families and those who can successfully raise funds pay about £2,000 a month to access full-leaf cannabis medicines via private prescription for children with rare forms of treatment-resistant epilepsy, while poorer parents are unable to afford the prescriptions.
Experts say that, despite the drug’s legality, rigid prescribing guidelines for doctors set by the British Paediatric Neurological Association – which cite a lack of clinical research and reference disputed theories about the mental health effects of cannabis – make getting hold of the medicine on the NHS difficult in practice.
A freedom of information (FoI) request to the NHS business services authority confirmed there were no new prescriptions for the oil in England between its legalisation and the end of February. There is understood to have been no change since.
No new NHS patients prescribed cannabis oil since legalisation
Mother of Alfie Dingley says parents are despondent at lack of access to full-extract oil
www.theguardian.com